[go: up one dir, main page]

WO2001077287A3 - A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide - Google Patents

A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide Download PDF

Info

Publication number
WO2001077287A3
WO2001077287A3 PCT/CN2001/000494 CN0100494W WO0177287A3 WO 2001077287 A3 WO2001077287 A3 WO 2001077287A3 CN 0100494 W CN0100494 W CN 0100494W WO 0177287 A3 WO0177287 A3 WO 0177287A3
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptide
globine
polynucleotide encoding
human uterine
discloses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/CN2001/000494
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001077287A2 (en
Inventor
Yumin Mao
Yi Xie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Biowindow Gene Development Inc
Original Assignee
Shanghai Biowindow Gene Development Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Biowindow Gene Development Inc filed Critical Shanghai Biowindow Gene Development Inc
Priority to AU63725/01A priority Critical patent/AU6372501A/en
Publication of WO2001077287A2 publication Critical patent/WO2001077287A2/en
Publication of WO2001077287A3 publication Critical patent/WO2001077287A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses a novel polypeptide, a human uterine globine 11, the polynucleotide encoding the polypeptide and the method for producing the polypeptide by DNA recombinant technology. The invention also discloses the uses of the polypeptide in methods for treating various diseases, such as malignant tumor, hemopathy, HIV infection, immunological disease, and various inflammation, etc. The invention also discloses the agonists against the polypeptide and the therapeutic action thereof. The invention also discloses the uses of the polynucleotide encoding the human uterine globine 11.
PCT/CN2001/000494 2000-03-27 2001-03-26 A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide Ceased WO2001077287A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU63725/01A AU6372501A (en) 2000-03-27 2001-03-26 A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN00115141A CN1315370A (en) 2000-03-27 2000-03-27 Polypeptide-human uteroglobin 11 and polynucleotide for coding it
CN00115141.X 2000-03-27

Publications (2)

Publication Number Publication Date
WO2001077287A2 WO2001077287A2 (en) 2001-10-18
WO2001077287A3 true WO2001077287A3 (en) 2002-04-18

Family

ID=4584610

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000494 Ceased WO2001077287A2 (en) 2000-03-27 2001-03-26 A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide

Country Status (3)

Country Link
CN (1) CN1315370A (en)
AU (1) AU6372501A (en)
WO (1) WO2001077287A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000004863A2 (en) * 1998-07-21 2000-02-03 Claragen, Inc. Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000004863A2 (en) * 1998-07-21 2000-02-03 Claragen, Inc. Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions

Also Published As

Publication number Publication date
AU6372501A (en) 2001-10-23
CN1315370A (en) 2001-10-03
WO2001077287A2 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
WO2001088084A3 (en) A novel polypeptide, a superoxide dismutase 11 and the polynucleotide encoding the polypeptide
WO2001075036A3 (en) A novel polypeptide, human immunophiline 14 and the polynucleotide encoding the polypeptide
WO2001075016A3 (en) A novel polypeptide, a human tyrosinase 16, and the polynucleotide encoding the polypeptide
WO2001077287A3 (en) A novel polypeptide, human uterine globine 11 and the polynucleotide encoding the polypeptide
WO2001075048A3 (en) A novel polypeptide, human ribosomal protein s11 23 and the polynucleotide encoding the polypeptide
WO2002000821A3 (en) A novel polypeptide, a human protein plp39 and the polynucleotide encoding the polypeptide
WO2001075011A3 (en) A novel polypeptide, cytochrome human constitution protein 10 and the polynucleotide encoding the polypeptide
WO2001075058A3 (en) A NOVEL POLYPEPTIDE, HUMAN AMINOACYL-tRNA SYNTHETASE 15 TYPE II AND THE POLYNUCLEOTIDE ENCODING THE POLYPEPTIDE
WO2001077286A3 (en) A novel polypeptide, human uterine globine 58 and the polynucleotide encoding the polypeptide
WO2001075053A3 (en) A novel polypeptide, human chaperonine 14 and the polynucleotide encoding the polypeptide
WO2001075056A3 (en) A novel polypeptide, human light-chain clathrine 20 and the polynucleotide encoding the polypeptide
WO2001083681A3 (en) A novel polypeptide, a human dihydroorotase 21 and the polynucleotide encoding the polypeptide
WO2001075024A3 (en) A novel polypeptide, nf-e2-associated human factor 13 and the polynucleotide encoding the polypeptide
WO2001094531A3 (en) A novel polypeptide, a human uterine globulin 12 and the polynucleotide encoding the polypeptide
WO2001075039A3 (en) A novel polypeptide, human rna helicase 10 and the polynucleotide encoding the polypeptide
WO2001075034A3 (en) A novel polypeptide, human peroxydase protein 15 and the polynucleotide encoding the polypeptide
WO2001075035A3 (en) A novel polypeptide, human peroxydase protein 9 and the polynucleotide encoding the polypeptide
WO2001075007A3 (en) A novel polypeptide, a tyrosinase 15 and the polynucleotide encoding the polypeptide
WO2001075062A3 (en) A novel polypeptide, human hydrogenase 10 and the polynucleotide encoding the polypeptide
WO2001075061A3 (en) A novel polypeptide, cdv-1-42 and the polynucleotide encoding the polypeptide
WO2001079431A3 (en) A novel polypeptide, a human pathway 15 protein with the huntingtine protein and the polynucleotide encoding the polypeptide
WO2001083682A3 (en) A novel polypeptide, a human pax protein 11.6 and the polynucleotide encoding the polypeptide
WO2002000828A3 (en) A novel polypeptide, a zinc-finger protein 34 and the polynucleotide encoding the polypeptide
WO2001075057A3 (en) A novel polypeptide, human ribosomal s4 protein 12 and the polynucleotide encoding the polypeptide
WO2001083687A3 (en) A novel polypeptide, a human pax protein 23 and the polynucleotide encoding the polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP